Suppr超能文献

利拉鲁肽对高脂饮食诱导的糖尿病小鼠的肾脏保护作用及机制

[The renal protective effect and mechanism of liraglutide in diabetic mice induced by high-fat diet].

作者信息

Fu C, Liang R Y, Xu F, Liang H, Mu P W, Zhu Y H, Tan Y, Deng H R, Wang M J, Cai M Y

机构信息

Department of Endocrinology and Metabolism, the Third Affiliated Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2019 May 28;99(20):1576-1581. doi: 10.3760/cma.j.issn.0376-2491.2019.20.012.

Abstract

To investigate the protective effect of liraglutide on kidney of diabetic mice induced by high-fat diet and its possible mechanisms. C57BL/6J male mice were randomly divided into normal chow diet (NC) group and high-fat diet (HFD) group, which were fed with normal chow diet and HFD for 12 weeks respectively. After diet challenge, the mice were randomly divided into normal control group, normal chow diet with liraglutide treatment (NC+Lira) group, HFD group and high-fat diet with liraglutide treatment (HFD+Lira) group. The mice in NC+Lira and HFD+Lira groups were given intraperitoneal injection of liraglutide (400 μg·kg(-1)·d(-1)) for 8 weeks, while mice in NC and HFD groups were given intraperitoneal injection of same amount of normal saline. Urinary albumin and creatinine levels were measured by enzyme-linked immunosorbent assay (ELISA). Renal morphology was observed by HE staining. The expression levels of silent mating type information regulation 2 homolog 1 (SIRT1) and thioredoxin-interacting protein (TXNIP) were determined by Western blot. Compared with HFD group, liraglutide significantly lowered the body weight [(30.98±1.29) g vs (39.43±2.58) g], fasting blood glucose (FBG) [(7.21±0.15) mmol/L vs (9.55±0.29) mmol/L] and urinary albumin/creatinine ratio (ACR) [(205.48±17.14) μg/mg vs (319.86±34.14) μg/mg] in HFD+Lira group (all 0.05). HE staining showed that glomerular hypertrophy of HFD group alleviated after liraglutide treatment. The expression level of TXNIP in the kidney of HFD mice significantly decreased after liraglutide treatment (0.41±0.10 vs 3.50±0.70), while expression level of SIRT1 significantly increased (0.75±0.15 vs 0.32±0.04) (both 0.05). Liraglutide could improve diabetic nephropathy by up-regulation of SIRT1 expression and down-regulation of TXNIP expression in diabetic mice induced by HFD.

摘要

探讨利拉鲁肽对高脂饮食诱导的糖尿病小鼠肾脏的保护作用及其可能机制。将C57BL/6J雄性小鼠随机分为正常饮食(NC)组和高脂饮食(HFD)组,分别给予正常饮食和高脂饮食12周。饮食干预后,将小鼠随机分为正常对照组、利拉鲁肽治疗的正常饮食组(NC+Lira)、高脂饮食组和利拉鲁肽治疗的高脂饮食组(HFD+Lira)。NC+Lira组和HFD+Lira组小鼠腹腔注射利拉鲁肽(400μg·kg⁻¹·d⁻¹)8周,而NC组和HFD组小鼠腹腔注射等量生理盐水。采用酶联免疫吸附测定(ELISA)法检测尿白蛋白和肌酐水平。通过HE染色观察肾脏形态。采用蛋白质印迹法检测沉默信息调节因子2同源物1(SIRT1)和硫氧还蛋白相互作用蛋白(TXNIP)的表达水平。与HFD组相比,利拉鲁肽显著降低了HFD+Lira组小鼠的体重[(30.98±1.29)g对(39.43±2.58)g]、空腹血糖(FBG)[(7.21±0.15)mmol/L对(9.55±0.29)mmol/L]和尿白蛋白/肌酐比值(ACR)[(205.48±17.14)μg/mg对(319.86±34.14)μg/mg](均P<0.05)。HE染色显示,利拉鲁肽治疗后HFD组肾小球肥大减轻。利拉鲁肽治疗后,HFD小鼠肾脏中TXNIP的表达水平显著降低(0.41±0.10对3.50±0.70),而SIRT1的表达水平显著升高(0.75±0.15对0.32±0.04)(均P<0.05)。利拉鲁肽可通过上调HFD诱导的糖尿病小鼠中SIRT1的表达和下调TXNIP的表达来改善糖尿病肾病。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验